cholesterol-lowering drugs might increase the risk of cancer

Patients are concerned about recent reports that many cholesterol-lowering drugs might increase the risk of cancer.

This was triggered by an article recently published in JAMA.

The authors suggest limiting the use of "statins" such as lovastatin...and fibrates such as gemfibrozil (Lopid).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote